(Q37988384)

26 August 2017

title

The significance of neuronal lateralisation in Parkinson's disease (English)

1 reference

26 August 2017

1 reference

P Riederer

1

1 reference

26 August 2017

J Sian-Hülsmann

series ordinal

2

1 reference

26 August 2017

publication date

26 February 2012

1 reference

Journal of Neural Transmission

26 August 2017

published in

1 reference

26 August 2017

volume

119

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

953-962

1 reference

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Parkinson's disease mouse models in translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Neuropsychological functioning in hemiparkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Asymmetrical development of the monoamine systems in 2,4-dichlorophenoxyacetic acid treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

A critical evaluation of the Braak staging scheme for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Nigrostriatal dopaminergic cell activity is under control by substantia nigra of the contralateral brain side: electrophysiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Parkinson's disease: insights from pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Does laterality of motor impairment tell us something about cognition in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Parkinson's disease as a disconnection syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Far field potentials from the brain stem after transcutaneous vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

The progression of pathology in longitudinally followed patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Formation and development of Lewy pathology: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Bilateral medial temporal lesions in Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Side and type of motor symptom influence cognition in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

21 January 2018

The Parkinson chimera

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

The neural circuitry of executive functions in healthy subjects and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Sound lateralization in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Progression of parkinsonian signs in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Unilateral Parkinson's disease, clinical and neuropathologic findings: A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Mood, side of motor symptom onset and pain complaints in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Dopaminergic agonists and muscarinic antagonists improve lateralization in hemiparkinsonian rats in a novel exploratory Y-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Deductive and inductive reasoning in Parkinson's disease patients and normal controls: review and experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Postencephalitic stereotyped involuntary movements responsive to L-Dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Diagnostic staging of Parkinson's disease: conceptual aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

The relationship of memory and cognition in Parkinson's disease to lateralisation of motor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Role of a lateralized parietal-basal ganglia circuit in hierarchical pattern perception: evidence from Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Lateralization of striatal dopamine (D2) receptors in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Relationship between striatal [123I]beta-CIT binding and four major clinical signs in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Side of onset of motor symptoms influences cognition in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Parkinson's disease shows perceptuomotor asymmetry unrelated to motor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Vagus nerve somatosensory evoked potentials in Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0775-1

Clinical predictors in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization

1 reference

12 December 2020

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

12 December 2020

Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance.

1 reference

12 December 2020

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

1 reference

12 December 2020

SPECT and PET imaging of the dopaminergic system in Parkinson's disease

1 reference

12 December 2020

Maternal effect on Parkinson's disease

1 reference

12 December 2020

Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats

1 reference

12 December 2020

Lateralization in male rats and dopaminergic system: evidence of right-side population bias

1 reference

12 December 2020

How much phenotypic variation can be attributed to parkin genotype?

1 reference

12 December 2020

The relevance of iron in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease

1 reference

12 December 2020

[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

1 reference

12 December 2020

Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model

1 reference

12 December 2020

Recent imaging advances in the diagnosis and management of Parkinson's disease

1 reference

12 December 2020

The effect on delayed-alternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey's brain.

1 reference

12 December 2020

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

1 reference

12 December 2020

Handedness and dominant side of symptoms in Parkinson's disease

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality. 1967.

1 reference

12 December 2020

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Bilateral morphological changes in the substantia nigra of the rat following unilateral damage of the striatum

1 reference

12 December 2020

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death

1 reference

12 December 2020

Behavioral lateralization in rats and dopaminergic system: individual and population laterality.

1 reference

12 December 2020

Models of basal ganglia function and pathophysiology of movement disorders.

1 reference

12 December 2020

Asymmetrical cognitive differences associated with hemiparkinsonism

1 reference

12 December 2020

The substantia nigra is also involved in Japanese encephalitis.

1 reference

12 December 2020

10.1007/S00702-012-0775-1

Identifiers

DOI

1 reference

26 August 2017

1 reference